STRATA Skin Sciences Reports Second Quarter 2022 Financial Results
HORSHAM, Pa. , Aug. 10, 2022 (GLOBE NEWSWIRE) -- STRATA Skin Sciences, Inc. (NASDAQ: SSKN), a medical technology company dedicated to developing, commercializing and marketing innovative products for the treatment of dermatologic conditions, today announced financial results for the second quarter
STRATA Skin Sciences Announces Upcoming KOL Call Hosted by Ladenburg Thalmann
Call to Highlight the Growing Psoriasis and Vitiligo Markets and the Importance of STRATA’s XTRAC Technology Within the Treatment Landscape HORSHAM, Pa. , Aug. 02, 2022 (GLOBE NEWSWIRE) -- STRATA Skin Sciences, Inc. (NASDAQ: SSKN), a medical technology company dedicated to developing,
STRATA Skin Sciences to Report Second Quarter 2022 Financial Results on August 10, 2022
HORSHAM, Pa. , July 27, 2022 (GLOBE NEWSWIRE) -- STRATA Skin Sciences, Inc. (NASDAQ: SSKN), a medical technology company dedicated to developing, commercializing and marketing innovative products for the treatment of dermatologic conditions, today announced that it plans to release its second
STRATA Skin Sciences Announces U.S. Commercial Launch of TheraClear®X Acne Therapy System
Combination of FDA-Cleared Technology and STRATA’s Partnership Program Delivers Ideal Platform to Enter Estimated $5.5 Billion Acne Care Market Offering Dermatologists New Treatment Option HORSHAM, Pa. , July 25, 2022 (GLOBE NEWSWIRE) -- STRATA Skin Sciences, Inc.
STRATA Skin Sciences to Participate in the Lytham Partners Summer 2022 Investor Conference
HORSHAM, Pa. , June 07, 2022 (GLOBE NEWSWIRE) -- STRATA Skin Sciences, Inc. (NASDAQ: SSKN), a medical technology company dedicated to developing, commercializing and marketing innovative products for the treatment of dermatologic conditions, announced today that it will be participating in the
STRATA Skin Sciences Names Michael E. Goodman as Head of International Sales
HORSHAM, Pa. , May 16, 2022 (GLOBE NEWSWIRE) -- STRATA Skin Sciences, Inc. (NASDAQ: SSKN), a medical technology company dedicated to developing, commercializing and marketing innovative products for the treatment of dermatologic conditions, today announced that Michael E.
STRATA Skin Sciences Reports First Quarter 2022 Financial Results
HORSHAM, Pa. , May 11, 2022 (GLOBE NEWSWIRE) -- STRATA Skin Sciences, Inc. (NASDAQ: SSKN), a medical technology company dedicated to developing, commercializing and marketing innovative products for the treatment of dermatologic conditions, today announced financial results for the first quarter
STRATA Skin Sciences to Report First Quarter 2022 Financial Results on May 11, 2022
HORSHAM, Pa. , April 27, 2022 (GLOBE NEWSWIRE) -- STRATA Skin Sciences, Inc. (NASDAQ: SSKN), a medical technology company dedicated to developing, commercializing and marketing innovative products for the treatment of dermatologic conditions, today announced that it plans to release its first
STRATA Skin Sciences Becomes Corporate Sponsor of the Global Vitiligo Foundation
HORSHAM, Pa. , March 30, 2022 (GLOBE NEWSWIRE) -- STRATA Skin Sciences , Inc. (NASDAQ: SSKN), a medical technology company dedicated to developing, commercializing, and marketing innovative products for the treatment of various autoimmune skin diseases, today announced that it has become a
STRATA Skin Sciences to Participate in the Lytham Partners Spring 2022 Investor Conference
HORSHAM, Pa. , March 28, 2022 (GLOBE NEWSWIRE) -- STRATA Skin Sciences, Inc. (NASDAQ: SSKN), a medical technology company dedicated to developing, commercializing and marketing innovative products for the treatment of dermatologic conditions, announced today that it will be participating in the